HKD 1.5
(-0.66%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -35.47 Million CNY | 95.63% |
2022 | -811.83 Million CNY | -674.03% |
2021 | -104.88 Million CNY | -109.8% |
2020 | 1.07 Billion CNY | 50.9% |
2019 | 709.34 Million CNY | 491.02% |
2018 | -181.4 Million CNY | -1204.6% |
2017 | 16.42 Million CNY | -94.5% |
2016 | 298.69 Million CNY | 149.41% |
2015 | -604.46 Million CNY | -90.36% |
2014 | -317.53 Million CNY | -678.75% |
2013 | 54.86 Million CNY | -91.15% |
2012 | 619.82 Million CNY | 24.97% |
2011 | 495.99 Million CNY | 46.89% |
2010 | 337.66 Million CNY | 0.27% |
2009 | 336.75 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 228.05 Million CNY | 0.0% |
2023 Q2 | -645.24 Million CNY | 0.0% |
2023 FY | -35.47 Million CNY | 95.63% |
2023 Q4 | 176.69 Million CNY | 0.0% |
2022 Q4 | -626.38 Million CNY | 0.0% |
2022 FY | -811.83 Million CNY | -674.03% |
2022 Q2 | -182.48 Million CNY | 0.0% |
2021 FY | -104.88 Million CNY | -109.8% |
2021 Q4 | -379.33 Million CNY | 0.0% |
2021 Q2 | 274.44 Million CNY | 0.0% |
2020 Q2 | 341.29 Million CNY | 0.0% |
2020 Q4 | 729.07 Million CNY | 0.0% |
2020 FY | 1.07 Billion CNY | 50.9% |
2019 Q4 | 663.88 Million CNY | 0.0% |
2019 Q2 | 45.46 Million CNY | 0.0% |
2019 FY | 709.34 Million CNY | 491.02% |
2018 FY | -181.4 Million CNY | -1204.6% |
2018 Q2 | -131.05 Million CNY | 0.0% |
2018 Q4 | -50.35 Million CNY | 0.0% |
2017 FY | 16.42 Million CNY | -94.5% |
2017 Q2 | -105.78 Million CNY | 0.0% |
2017 Q4 | 122.2 Million CNY | 0.0% |
2016 Q2 | 3.46 Million CNY | 0.0% |
2016 FY | 298.69 Million CNY | 149.41% |
2016 Q4 | 295.23 Million CNY | 0.0% |
2015 Q4 | -297.21 Million CNY | 0.0% |
2015 FY | -604.46 Million CNY | -90.36% |
2015 Q2 | -307.25 Million CNY | 0.0% |
2014 FY | -317.53 Million CNY | -678.75% |
2014 Q4 | -213.98 Million CNY | 0.0% |
2014 Q2 | -103.55 Million CNY | 0.0% |
2013 Q4 | 1.93 Million CNY | 0.0% |
2013 Q2 | 52.93 Million CNY | 0.0% |
2013 FY | 54.86 Million CNY | -91.15% |
2012 Q1 | 155.26 Million CNY | 0.0% |
2012 Q3 | 155.26 Million CNY | 0.0% |
2012 Q2 | 155.26 Million CNY | 0.0% |
2012 Q4 | 190.27 Million CNY | 22.55% |
2012 FY | 619.82 Million CNY | 24.97% |
2011 Q4 | 155.26 Million CNY | 25.32% |
2011 Q2 | 123.89 Million CNY | 0.0% |
2011 FY | 495.99 Million CNY | 46.89% |
2011 Q3 | 123.89 Million CNY | 0.0% |
2011 Q1 | 123.89 Million CNY | 0.0% |
2010 FY | 337.66 Million CNY | 0.27% |
2010 Q3 | 84.36 Million CNY | 0.0% |
2010 Q4 | 123.89 Million CNY | 46.85% |
2010 Q1 | 84.36 Million CNY | 0.0% |
2010 Q2 | 84.36 Million CNY | 0.0% |
2009 Q2 | 79.66 Million CNY | 0.0% |
2009 FY | 336.75 Million CNY | 0.0% |
2009 Q3 | 79.66 Million CNY | 0.0% |
2009 Q4 | 84.36 Million CNY | 5.9% |
2009 Q1 | 79.66 Million CNY | 0.0% |
2008 Q4 | 79.66 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | 338.206% |
Lee & Man Chemical Company Limited | 473.28 Million HKD | 107.496% |